RHONDA CHOI: Open Payments
NPI 1013428366 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,188 in 105 payments from 15 companies in 2025. Trend: 2023 $94 · 2024 $2,981 · 2025 $2,188
Food & beverage: $2,093Education: $95
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 52 | $994 |
| Janssen Biotech, Inc. | 13 | $302 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $235 |
| Ferring Pharmaceuticals Inc. | 4 | $109 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $103 |
| Aimmune Therapeutics, Inc. | 4 | $86 |
| Regeneron Healthcare Solutions, Inc. | 3 | $74 |
| Phathom Pharmaceuticals, Inc. | 5 | $69 |
| Madrigal Pharmaceuticals | 2 | $58 |
| Novo Nordisk Inc | 2 | $37 |
Products named: RINVOQ, LINZESS, TREMFYA, ENTYVIO, CREON, SKYRIZI, REBYOTA, ZENPEP.
Industry payments across TX — which companies pay providers there.
